Citation

Velaparthi U, Darne CP, Warrier J, Liu P, Rahaman H, Augustine-Rauch K, Parrish K, Yang Z, Swanson J, Brown J, Dhar G, Anandam A, Holenarsipur VK, Palanisamy K, Wautlet BS, Fereshteh MP, Lippy J, Tebben AJ, Sheriff S, Ruzanov M, Yan C, Gupta A, Gupta AK, Vetrichelvan M, Mathur A, Gelman M, Singh R, Kinsella T, Murtaza A, Fargnoli J, Vite G, Borzilleri RM.: Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent. ACS Med Chem Lett, Volume 11 (2), 2020

Authors

Anandam A, Augustine-Rauch K, Borzilleri RM., Brown J, Darne CP, Dhar G, Fargnoli J, Fereshteh MP, Gelman M, Gupta A, Gupta AK, Holenarsipur VK, Kinsella T, Lippy J, Liu P, Mathur A, Murtaza A, Palanisamy K, Parrish K, Rahaman H, Ruzanov M, Sheriff S, Singh R, Swanson J, Tebben AJ, Velaparthi U, Vetrichelvan M, Vite G, Warrier J, Wautlet BS, Yan C, Yang Z

Journal

ACS Med Chem Lett

Year

2020

DOI

10.1021/acsmedchemlett.9b00552

PubMed

32071685

Machine-readable

REST APIRDF